Cargando…
Relationship Between the Response to Antibody Therapy and Symptoms of Depression and Anxiety Disorders in Patients with Severe Asthma
PURPOSE: Asthma is associated with a high prevalence of psychopathological disorders, especially depressive disorders or anxiety. In patients with uncontrolled severe asthma, monoclonal antibody (mAb)-therapy positively influenced control of mental disorders. Therefore, we evaluated the impact of an...
Autores principales: | Plank, Pia Maria, Hinze, Christopher Alexander, Campbell, Victoria, Konwert, Stefanie, Welte, Tobias, Drick, Nora, Kayser, Moritz Z, Suhling, Hendrik, Fuge, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122462/ https://www.ncbi.nlm.nih.gov/pubmed/37096014 http://dx.doi.org/10.2147/JAA.S403296 |
Ejemplares similares
-
Eosinophilic cationic protein as marker for response to antibody therapy in severe asthma
por: Franceschi, Elisa, et al.
Publicado: (2022) -
The impact of anti-eosinophilic therapy on exercise capacity and inspiratory muscle strength in patients with severe asthma
por: Franceschi, Elisa, et al.
Publicado: (2023) -
Anti-IL-5 therapy in patients with severe eosinophilic asthma – clinical efficacy and possible criteria for treatment response
por: Drick, Nora, et al.
Publicado: (2018) -
Influence of anti-interleukin (IL)-5/anti-IL-5 receptor-α treatment on work productivity in patients with severe eosinophilic asthma
por: Drick, Nora, et al.
Publicado: (2023) -
Treatment with interleukin (IL)-5/IL-5 receptor antibodies in patients with severe eosinophilic asthma and COPD
por: Drick, Nora, et al.
Publicado: (2022)